NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ruilaipu (Hangzhou) Medical Technology Co., Ltd.

Ruilaipu (Hangzhou) Medical Technology Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttp://ruilaipu.com/

Last Round

Series B

Sep 26, 2024

Total Funding Raised

$14.4M

Company Overview

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is a medical technology company that develops high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) detection systems and automated sample pretreatment platforms for clinical diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

mass spectrometryHPLC-MS/MSlaboratory automationclinical diagnosticssample pretreatmentmedical instrumentationprecision medicinemass speclab automationinorganic mass spectrometerclinical lab equipmentanalytical chemistrydiagnostic hardwarebiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 26, 2024
Series A ExtensionFeb 6, 2023
Series A ExtensionMar 31, 2022
Series A ExtensionMay 31, 2021
Series ADec 18, 2020
Angel
Oct 1, 2019

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Investors

Notable investors and investment history

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. investors
InvestorRounds
3H Health InvestmentSeries A Extension
Legend CapitalSeries A Extension, Series A
Guangzhou Industrial Investment Holding GroupSeries B
辰德资本Series A Extension, Series B, Series A, Angel
Vinno CapitalSeries B
Huagai CapitalSeries A, Series A Extension
CPESeries A Extension

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Year Founded2019
Last FundingSep 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.